Full Text Journal Articles from
Abstract 30737607


Find full text journal articles

Prevalence and current therapy in chronic liver disorders.

PMID: 30737607 (view PubMed database entry)
DOI: 10.1007/s10787-019-00562-z (read at publisher's website )

Muhammad Daniyal, Muhammad Akram, Rida Zainab, Naveed Munir, Aamir Sharif, Syed Muhammad Ali Shah, Bin Liu, Wei Wang,

BACKGROUND:Herbal medicine plays an important role in health, particularly in remote parts of developing areas with few health facilities. According to WHO estimates, about three-quarters of the world's population currently use herbs or traditional medicines to treat various ailments, including liver diseases. Several studies have found that the use of medicinal plants was effective in the treatment of infectious and non-infectious diseases. Hepatitis and liver cirrhosis associated with many clinical manifestations can be treated with allopathic medicines, but reports of a number of side effects including immunosuppression, bone marrow suppression, and renal complications have motivated researchers to explore more natural herbal medicines with low or no side effects and with high efficacy in treating hepatic diseases. METHODS:Databases including PubMed, Medline, and Google Scholar were searched for findings on the hepatoprotective effects of plants. RESULTS:Various medicinal plants are used for the treatment of liver disorders. The range of alternative therapies is huge, and they are used worldwide, either as part of primary health care or in combination with conventional medicine. Hepatoprotective plants contain a variety of chemical constituents including flavonoids, alkaloids, glycosides, carotenoids, coumarins, phenols, essential oil, organic acids, monoterpenes, xanthenes, lignans, and lipids. CONCLUSION:This review shows that numerous plants are found to contain hepatoprotective compounds. However, further studies are needed to determine their association with existing regimes of antiviral medicines and to develop evidence-based alternative medicine to cure different kinds of liver disease in humans.

Inflammopharmacology (Inflammopharmacology)
[2019, 27(2):213-231]

Cited: 1 time

AltMetric Statistics

Additional resources:


0.4018 s